Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?
作者信息
Angulo Paul
出版信息
Hepatology. 2010 Feb;51(2):373-5. doi: 10.1002/hep.23521.
Abstract
摘要
相似文献
1
Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?非酒精性脂肪性肝病的长期死亡率：肝脏组织学是否具有任何预后意义？
Hepatology. 2010 Feb;51(2):373-5. doi: 10.1002/hep.23521.
2
The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.肝组织学对预测非酒精性脂肪性肝炎有临床意义结局的相关性。
Clin Liver Dis. 2012 Aug;16(3):487-504. doi: 10.1016/j.cld.2012.05.006. Epub 2012 Jun 27.
3
NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.非酒精性脂肪性肝病纤维化评分：用于预测非酒精性脂肪性肝病患者死亡和肝脏并发症的预后指标。
World J Gastroenterol. 2013 Feb 28;19(8):1219-29. doi: 10.3748/wjg.v19.i8.1219.
4
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.非酒精性脂肪性肝病伴进展性肝纤维化或肝硬化的自然史：一项国际合作研究。
Hepatology. 2011 Oct;54(4):1208-16. doi: 10.1002/hep.24491. Epub 2011 Aug 9.
5
Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?在丙型肝炎病毒治疗效果更佳的时代，非酒精性脂肪性肝炎（NASH）患病率的上升会使NASH成为更致命的疾病吗？
Hepatology. 2011 Oct;54(4):1118-20. doi: 10.1002/hep.24634.
6
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.美国非酒精性脂肪性肝病成人患者中无创性纤维化标志物与死亡率之间的关系。
Hepatology. 2013 Apr;57(4):1357-65. doi: 10.1002/hep.26156. Epub 2013 Jan 25.
7
Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation.非酒精性脂肪性肝病肝移植后复发的演变。
Liver Transpl. 2012 Oct;18(10):1147-53. doi: 10.1002/lt.23499.
8
Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality.非酒精性脂肪性肝炎的病理诊断标准：方案间一致性和预测肝相关死亡率的能力。
Hepatology. 2011 Jun;53(6):1874-82. doi: 10.1002/hep.24268. Epub 2011 May 14.
9
Mortality in nonalcoholic fatty liver disease: clues from the Cremona study.非酒精性脂肪性肝病的死亡率：来自克雷莫纳研究的线索。
Hepatology. 2011 Jul;54(1):6-8. doi: 10.1002/hep.24445.
10
Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.非酒精性脂肪性肝炎肝硬化肝移植后复发疾病。
Liver Transpl. 2009 Dec;15(12):1843-51. doi: 10.1002/lt.21943.
引用本文的文献
1
Liver cirrhosis in 2021: Global Burden of Disease study.2021年肝硬化：全球疾病负担研究
PLoS One. 2025 Jul 18;20(7):e0328493. doi: 10.1371/journal.pone.0328493. eCollection 2025.
2
Normative Modeling Reveals Age-Atypical Cortical Thickness Differences Between Hepatic Steatosis and Fibrosis in Non-Alcoholic Fatty Liver Disease.规范建模揭示了非酒精性脂肪性肝病中肝脂肪变性和肝纤维化之间的年龄非典型皮质厚度差异。
Brain Behav. 2025 Apr;15(4):e70466. doi: 10.1002/brb3.70466.
3
Clinical cohort of nonalcoholic fatty liver disease in a primary care setting.基层医疗环境中非酒精性脂肪性肝病的临床队列
J Family Med Prim Care. 2024 Aug;13(8):2958-2963. doi: 10.4103/jfmpc.jfmpc_1769_23. Epub 2024 Jul 26.
4
Liver organoids: updates on generation strategies and biomedical applications.肝脏类器官：生成策略与生物医学应用的最新进展
Stem Cell Res Ther. 2024 Aug 7;15(1):244. doi: 10.1186/s13287-024-03865-3.
5
Identification of Predictors of Non-alcoholic Steatohepatitis and Its Severity in Individuals Undergoing Bariatric Surgery.识别接受减重手术患者非酒精性脂肪性肝炎及其严重程度的预测因子。
Obes Surg. 2024 Feb;34(2):456-466. doi: 10.1007/s11695-023-06986-5. Epub 2023 Dec 14.
6
Metabolomic Phenotype of Hepatic Steatosis and Fibrosis in Mexican Children Living with Obesity.墨西哥肥胖儿童的肝脂肪变性和纤维化的代谢组学表型。
Medicina (Kaunas). 2023 Oct 7;59(10):1785. doi: 10.3390/medicina59101785.
7
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases.台湾肝病研究学会-台湾心脏学会代谢相关脂肪性肝病与心血管疾病管理之立场声明。
Clin Mol Hepatol. 2024 Jan;30(1):16-36. doi: 10.3350/cmh.2023.0315. Epub 2023 Oct 4.
8
Combination therapies in nonalcoholic fatty liver disease using antidiabetic and disease-specific drugs.使用抗糖尿病药物和疾病特异性药物治疗非酒精性脂肪性肝病的联合疗法。
Ann Gastroenterol. 2023 Jul-Aug;36(4):378-391. doi: 10.20524/aog.2023.0806. Epub 2023 May 29.
9
Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.采用磁共振波谱技术对肝脏脂肪酸进行特征分析，以评估内皮型一氧化氮合酶（eNOS）小鼠代谢性非酒精性脂肪性肝病/非酒精性脂肪性肝炎模型中二甲双胍治疗反应。
NMR Biomed. 2023 Aug;36(8):e4932. doi: 10.1002/nbm.4932. Epub 2023 Apr 11.
10
Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中肝纤维化的非侵入性生物标志物
Clin Mol Hepatol. 2023 Apr;29(2):398-400. doi: 10.3350/cmh.2023.0045. Epub 2023 Feb 13.
本文引用的文献
1
Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.在 28 年的随访中，肝功能检查升高的受试者生存率降低。
Hepatology. 2010 Feb;51(2):595-602. doi: 10.1002/hep.23314.
2
Final results of a long-term, clinical follow-up in fatty liver patients.脂肪肝患者长期临床随访的最终结果。
Scand J Gastroenterol. 2009;44(10):1236-43. doi: 10.1080/00365520903171284.
3
Long-term follow-up of patients with nonalcoholic fatty liver.非酒精性脂肪肝患者的长期随访
Clin Gastroenterol Hepatol. 2009 Feb;7(2):234-8. doi: 10.1016/j.cgh.2008.11.005. Epub 2008 Nov 7.
4
Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.非酒精性脂肪性肝炎所致肝硬化与慢性丙型肝炎所致肝硬化的临床特征及转归比较
J Gastroenterol Hepatol. 2009 Feb;24(2):248-54. doi: 10.1111/j.1440-1746.2008.05640.x. Epub 2008 Nov 20.
5
Long-term follow-up of patients with NAFLD and elevated liver enzymes.非酒精性脂肪性肝病（NAFLD）及肝酶升高患者的长期随访
Hepatology. 2006 Oct;44(4):865-73. doi: 10.1002/hep.21327.
6
Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的组织病理学评估中的观察者间变异性。
Hepatol Res. 2005 Oct;33(2):122-7. doi: 10.1016/j.hepres.2005.09.018.
7
Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.非酒精性脂肪性肝炎和丙型肝炎所致肝硬化结局的异同
Hepatology. 2006 Apr;43(4):682-9. doi: 10.1002/hep.21103.
8
The natural history of nonalcoholic fatty liver disease: a population-based cohort study.非酒精性脂肪性肝病的自然史：一项基于人群的队列研究。
Gastroenterology. 2005 Jul;129(1):113-21. doi: 10.1053/j.gastro.2005.04.014.
9
Sampling variability of liver biopsy in nonalcoholic fatty liver disease.非酒精性脂肪性肝病肝活检的抽样变异性
Gastroenterology. 2005 Jun;128(7):1898-906. doi: 10.1053/j.gastro.2005.03.084.
10
Design and validation of a histological scoring system for nonalcoholic fatty liver disease.非酒精性脂肪性肝病组织学评分系统的设计与验证
Hepatology. 2005 Jun;41(6):1313-21. doi: 10.1002/hep.20701.
Zotero 插件